| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/10/2006 | US7119118 90-95% eicosapentaenoic acid (EPA) and < 5% of docosahexaenoic acid (DHA); treating psychiatric or central nervous disorders |
| 10/10/2006 | US7119117 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 10/10/2006 | US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens |
| 10/10/2006 | US7119115 For therapy of treating tumors or cancerous cells |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 10/10/2006 | US7119107 Pyridone derivatives |
| 10/10/2006 | US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist |
| 10/10/2006 | US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | US7118905 Nucleic acid encoding angiogenesis inhibitor |
| 10/10/2006 | US7118903 Comprises genetically engineered protein for use in treatment and prevention of cancer, obesity, cardiac, vascular, neurologic and or aging disorders |
| 10/10/2006 | US7118856 Enzyme catalyst; polypeptides; crystal structure |
| 10/10/2006 | US7118769 For therapy of illnesses of the cardio-vascular system |
| 10/10/2006 | CA2356391C Transdermal drug delivery system |
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 10/10/2006 | CA2253407C Inorganic ion receptor-active compounds |
| 10/10/2006 | CA2231292C Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2214418C Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 10/10/2006 | CA2211889C Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines |
| 10/10/2006 | CA2207323C Use of pramipexole as a neuroprotective agent |
| 10/05/2006 | WO2006105219A2 T cell therapy for the treatment of cachexia and chronic diseases |
| 10/05/2006 | WO2006105217A2 Spirocyclic thrombin receptor antagonists |
| 10/05/2006 | WO2006104402A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104400A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104399A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104398A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104396A1 Pre-complexed copper antagonist compositions |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104190A1 Par-2 agonist |
| 10/05/2006 | WO2006104153A1 Composition for increasing anti-oxidation activity in blood |
| 10/05/2006 | WO2006103275A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006103273A1 Substituted piperidines as renin inhibitors |
| 10/05/2006 | WO2006102717A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
| 10/05/2006 | WO2006091800A3 Novel pyridine derivatives as potassium ion channel openers |
| 10/05/2006 | WO2006076595A8 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 10/05/2006 | WO2006055747A3 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 10/05/2006 | WO2006034184A3 Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases |
| 10/05/2006 | WO2006015124A3 Fused ring heterocycle kinase modulators |
| 10/05/2006 | WO2005044244A3 Use of mrp4-inhibitors for the treatment and/or prophylaxis of cardiovascular diseases |
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 10/05/2006 | US20060223865 Therapeutic combination |
| 10/05/2006 | US20060223836 New phenylalanine derivatives |
| 10/05/2006 | US20060223828 Substituted chroman derivatives |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | US20060223815 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060222638 Cholesterol biosynthesis pathway modulators and uses thereof |
| 10/05/2006 | DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 10/05/2006 | DE102005015040A1 Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 10/05/2006 | DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments |
| 10/05/2006 | CA2610502A1 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| 10/05/2006 | CA2601699A1 Substituted piperidines |
| 10/05/2006 | CA2601575A1 Spirocyclic thrombin receptor antagonists |
| 10/05/2006 | CA2601108A1 3,4,5-substituted piperidines as renin inhibitors |
| 10/05/2006 | CA2504439A1 External preparation for improving blood flow |
| 10/04/2006 | EP1707567A1 Novel fused-ring compound |
| 10/04/2006 | EP1707566A1 Deazapurines and uses thereof |
| 10/04/2006 | EP1707563A2 Methods and compositions utilizing quinazolinones |
| 10/04/2006 | EP1707215A1 Remedy for angitis |
| 10/04/2006 | EP1707195A1 Retinoic acid-containing remedy for diabetes |
| 10/04/2006 | EP1706413A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 10/04/2006 | EP1706400A1 Phenyl- 4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl -amine derivatives as igf-ir inhibitors |
| 10/04/2006 | EP1706386A1 Bicyclic derivatives as ppar modulators |
| 10/04/2006 | EP1626724A4 Method and kit for regulation of microvascular tone |
| 10/04/2006 | EP1487831B1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs |
| 10/04/2006 | EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 10/04/2006 | EP1406900B1 Novel compounds, their preparation and use |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | EP1368019B1 Esmolol formulation |
| 10/04/2006 | EP1253945B1 Ace inhibitor-vasopressin antagonist combinations |
| 10/04/2006 | EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof |
| 10/04/2006 | EP1097382B1 Imidazoline receptor binding compounds |
| 10/04/2006 | EP1027047B1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 10/04/2006 | EP0841925B1 Endothelin receptor antagonists |
| 10/04/2006 | CN1842344A Use of human fibrinogen a alpha or b beta chain peptide for treating shock |
| 10/04/2006 | CN1842339A Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| 10/04/2006 | CN1842338A Use of lornoxicam or lornoxicam analogue compounds |
| 10/04/2006 | CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 10/04/2006 | CN1840186A Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 10/04/2006 | CN1840170A Chinese proprietary medicine for treating cerebral thrombosis |
| 10/04/2006 | CN1840153A Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof |
| 10/04/2006 | CN1840149A Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process |
| 10/04/2006 | CN1840140A Soft capsule of ultra-micro powder and preparation method thereof |
| 10/04/2006 | CN1840128A Medicine for treating cardiovascular disease |
| 10/04/2006 | CN1840080A Pill preparation with ultramicro powder and preparation method thereof |
| 10/04/2006 | CN1840079A Soft capsule preparation with ultramicro powder and preparation method thereof |
| 10/04/2006 | CN1840078A Quality control method of 'Sheng Mai' powder |